Ficolin-3 Antibody (FCN334) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-23573B
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Immunoprecipitation
Label
Biotin
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # FCN334
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Ficolin-3 Antibody (FCN334) [Biotin]
Immunogen
Recombinant human H-ficolin
Epitope
Not determined
Reactivity Notes
Human
Specificity
Clone FCN334 reacts specifically with H-ficolin. No cross-reaction has been observed with L- or M-ficolin
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for Ficolin-3 Antibody (FCN334) [Biotin]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Ficolin-3
Long Name
Ficolin [Collagen/Fibrinogen Domain Containing] 3
Alternate Names
FCN3, FCNH, Ficolin3, H-Ficolin, HAKA1
Gene Symbol
FCN3
Additional Ficolin-3 Products
Product Documents for Ficolin-3 Antibody (FCN334) [Biotin]
Product Specific Notices for Ficolin-3 Antibody (FCN334) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...